Search Results
Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.
Employing Expertise During a Pandemic
Our senior medical lead and infectious disease specialist discusses our Worldwide Medical team's response to COVID-19.
Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the U.S. Food and Drug Administration (FDA) has granted the De Novo application for Theranova, the company’s novel dialysis membrane.
Baxter to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the virtual Morgan Stanley 18th Annual Global Healthcare Conference via webcast on Wednesday, September 16, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 12:30 p.m. Eastern Time.
Baxter to Present at the Wells Fargo Virtual Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2020 Wells Fargo Virtual Healthcare Conference via webcast on Wednesday, September 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through October 9, 2020.
Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Regiocit, the company’s replacement solution that contains citrate for regional citrate anticoagulation of the extracorporeal circuit.
Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During COVID-19 Pandemic
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) for the company’s HF20 Set and ST Set used in continuous renal replacement therapy (CRRT).
Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy For Nurses in the U.S.
Baxter International, Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the PD Excellence Academy, a new virtual training platform and educational resource center to help nurses develop their PD skills to deliver optimal patient care. The platform also offers a benefit to employers, including dialysis clinic administrators and nephrologists, who now have an additional resource available to develop and retain talent.
Baxter Reports Second-Quarter 2020 Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2020 and provided its outlook for full-year 2020.
Baxter and Ayogo Announce Partnership for Unique Digital Health Solutions for Home Dialysis
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science-based digital health company, announced the expansion of their partnership to support the needs of patients with kidney disease through digital health solutions.